Cargando…

Development of an IgG4-RD Responder Index

IgG4-related disease (IgG4-RD) is a multiorgan inflammatory disease in which diverse organ manifestations are linked by common histopathological and immunohistochemical features. Prospective studies of IgG4-RD patients are required to clarify the natural history, long-term prognosis, and treatment a...

Descripción completa

Detalles Bibliográficos
Autores principales: Carruthers, Mollie N., Stone, John H., Deshpande, Vikram, Khosroshahi, Arezou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348627/
https://www.ncbi.nlm.nih.gov/pubmed/22611406
http://dx.doi.org/10.1155/2012/259408
_version_ 1782232401055842304
author Carruthers, Mollie N.
Stone, John H.
Deshpande, Vikram
Khosroshahi, Arezou
author_facet Carruthers, Mollie N.
Stone, John H.
Deshpande, Vikram
Khosroshahi, Arezou
author_sort Carruthers, Mollie N.
collection PubMed
description IgG4-related disease (IgG4-RD) is a multiorgan inflammatory disease in which diverse organ manifestations are linked by common histopathological and immunohistochemical features. Prospective studies of IgG4-RD patients are required to clarify the natural history, long-term prognosis, and treatment approaches in this recently recognized condition. Patients with IgG4-RD have different organ manifestations and are followed by multiple specialties. Divergent approaches to the assessment of patients can complicate the interpretation of studies, emphasizing the critical need for validated outcome measures, particularly assessments of disease activity and response to treatment. We developed a prototype IgG4-RD Responder Index (IgG4-RD RI) based on the approach used in the development of the Birmingham Vasculitis Activity Score for Wegener's granulomatosis (BVAS/WG). The IgG4-RD RI was refined by members of the International IgG4-RD Symposium Organizing Committee in a paper case exercise. The revised instrument was applied retrospectively to fifteen IgG4-RD patients at our institution. Those scores were compared to physician's global assessment scale for the same visits. This paper describes the philosophy and goals of the IgG4-RD RI, the steps in the development of this instrument to date, and future plans for validation of this instrument as an outcome measure.
format Online
Article
Text
id pubmed-3348627
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33486272012-05-18 Development of an IgG4-RD Responder Index Carruthers, Mollie N. Stone, John H. Deshpande, Vikram Khosroshahi, Arezou Int J Rheumatol Clinical Study IgG4-related disease (IgG4-RD) is a multiorgan inflammatory disease in which diverse organ manifestations are linked by common histopathological and immunohistochemical features. Prospective studies of IgG4-RD patients are required to clarify the natural history, long-term prognosis, and treatment approaches in this recently recognized condition. Patients with IgG4-RD have different organ manifestations and are followed by multiple specialties. Divergent approaches to the assessment of patients can complicate the interpretation of studies, emphasizing the critical need for validated outcome measures, particularly assessments of disease activity and response to treatment. We developed a prototype IgG4-RD Responder Index (IgG4-RD RI) based on the approach used in the development of the Birmingham Vasculitis Activity Score for Wegener's granulomatosis (BVAS/WG). The IgG4-RD RI was refined by members of the International IgG4-RD Symposium Organizing Committee in a paper case exercise. The revised instrument was applied retrospectively to fifteen IgG4-RD patients at our institution. Those scores were compared to physician's global assessment scale for the same visits. This paper describes the philosophy and goals of the IgG4-RD RI, the steps in the development of this instrument to date, and future plans for validation of this instrument as an outcome measure. Hindawi Publishing Corporation 2012 2012-04-24 /pmc/articles/PMC3348627/ /pubmed/22611406 http://dx.doi.org/10.1155/2012/259408 Text en Copyright © 2012 Mollie N. Carruthers et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Carruthers, Mollie N.
Stone, John H.
Deshpande, Vikram
Khosroshahi, Arezou
Development of an IgG4-RD Responder Index
title Development of an IgG4-RD Responder Index
title_full Development of an IgG4-RD Responder Index
title_fullStr Development of an IgG4-RD Responder Index
title_full_unstemmed Development of an IgG4-RD Responder Index
title_short Development of an IgG4-RD Responder Index
title_sort development of an igg4-rd responder index
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348627/
https://www.ncbi.nlm.nih.gov/pubmed/22611406
http://dx.doi.org/10.1155/2012/259408
work_keys_str_mv AT carruthersmollien developmentofanigg4rdresponderindex
AT stonejohnh developmentofanigg4rdresponderindex
AT deshpandevikram developmentofanigg4rdresponderindex
AT khosroshahiarezou developmentofanigg4rdresponderindex